세리벨 (CBLL) 주가

세리벨(CBLL)는 NAS에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $24.37 (-2.52%), 시가총액 $624.54M.

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015.

핵심 지표

세리벨의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 XTS에서 실시간으로 확인할 수 있습니다.

세리벨 재무 요약

애널리스트 전망

핵심 재무비율 · 수익성 · 성장성

자주 묻는 질문

세리벨(CBLL) 현재 주가는 얼마인가요?

세리벨의 현재 주가는 $24.37 (-2.52%)입니다. XTS에서 실시간 시세와 차트를 확인할 수 있습니다.

세리벨(CBLL) 시가총액은 얼마인가요?

세리벨의 시가총액은 약 $624.54M입니다.

세리벨(CBLL)은 어떤 기업인가요?

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs…